TEM

Tempus AI (TEM)

Tempus AI Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TEM

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/01/09	06:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2025/01/09	01:58	Business Wire	Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms	NASDAQ:TEM	Tempus AI Inc
2025/01/08	22:30	Business Wire	Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms	NASDAQ:TEM	Tempus AI Inc
2025/01/07	22:30	Business Wire	Tempus to Present at 43rd Annual J.P. Morgan Healthcare Conference	NASDAQ:TEM	Tempus AI Inc
2025/01/04	06:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2025/01/03	09:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/19	10:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/19	10:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/19	10:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/19	10:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/19	10:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/18	22:30	Business Wire	Tempus Now an In-Network Provider for Blue Cross Blue Shield Illinois, Blue Shield California, and Avalon Healthcare Solutions	NASDAQ:TEM	Tempus AI Inc
2024/12/17	22:30	Business Wire	New CMS Decision Provides Medicare Coverage for the Clinical Use of the Tempus ECG-AF Device	NASDAQ:TEM	Tempus AI Inc
2024/12/16	22:00	Business Wire	Personalis and Tempus Expand Collaboration to Biopharma	NASDAQ:TEM	Tempus AI Inc
2024/12/14	08:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/14	08:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/14	08:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/14	08:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/14	08:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/13	07:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/13	06:48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/12	07:03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/12	07:02	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/12	07:01	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/12	07:01	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TEM	Tempus AI Inc
2024/12/12	07:01	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:TEM	Tempus AI Inc
2024/11/25	22:30	Business Wire	Tempus to Participate in the Piper Sandler 36th Annual Healthcare Conference	NASDAQ:TEM	Tempus AI Inc
2024/11/13	06:30	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:TEM	Tempus AI Inc
2024/11/12	22:30	Business Wire	Tempus Molecular Profiling Integration Now Available Through Flatiron’s OncoEMR®	NASDAQ:TEM	Tempus AI Inc
2024/11/11	22:30	Business Wire	Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care	NASDAQ:TEM	Tempus AI Inc